Pharmaceutical R&D: An Area Of Government Focus

BMI View: While Belgium is not a major hub for research and development (R&D) compared with some of its European neighbours, we believe the country is establishing itself as a centre for biotechnology. We note that expenditure on pharmaceutical R&D in Belgium as a percentage of that in Europe increased from 2.3% in 1990 to 7.0% in 2009, and further that employment in sector R&D in Belgium as a percentage of the European total increased from 2.4% in 1990 to 3.1% in 2009.

To read the full article, please choose one of the following options: